R1	Has_value Arg1:T1 Arg2:T2	
R2	AND Arg1:T3 Arg2:T4	
R3	AND Arg1:T5 Arg2:T6	
R4	AND Arg1:T7 Arg2:T8	
R5	Has_value Arg1:T9 Arg2:T10	
R6	Subsumes Arg1:T5 Arg2:T7	
R7	AND Arg1:T12 Arg2:T13	
R8	Has_negation Arg1:T12 Arg2:T14	
R9	Has_value Arg1:T15 Arg2:T16	
R10	Subsumes Arg1:T15 Arg2:T12	
R11	Has_mood Arg1:T21 Arg2:T20	
R13	multi Arg1:T30 Arg2:T27	
R14	multi Arg1:T29 Arg2:T28	
R15	Subsumes Arg1:T5 Arg2:T9	
T1	Person 27 31	aged
T2	Value 32 55	from 18 to 65 years old
T3	Person 92 98	Female
T4	Procedure 123 143	contraceptive method
T5	Condition 435 462	allergic contact dermatitis
T6	Drug 466 493	para-phenylenediamine (PPD)
T7	Condition 520 538	contact dermatitis
T8	Drug 516 519	PPD
T9	Measurement 552 567	PPD patch tests
T10	Value 543 551	positive
T12	Condition 625 652	allergic contact dermatitis
T13	Drug 621 624	PPD
T14	Negation 607 609	No
T15	Measurement 670 684	PPD patch test
T16	Value 661 669	negative
T18	Condition 402 410	allergic
T19	Observation 587 594	healthy
T20	Mood 146 160	Feasibility of
T21	Post-eligibility 161 174	patch testing
T22	Person 58 70	Both genders
T23	Mood 195 205	be able to
T24	Informed_consent 206 246	understand and sign the Informed Consent
T25	Informed_consent 252 291	comply with all aspects of the protocol
T27	Observation 311 349	registered in a social security system
T28	Observation 360 385	health insurance coverage
T29	Non-query-able 360 385	health insurance coverage
T30	Non-query-able 311 349	registered in a social security system
